NCT07529873
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07529873
Title Phase II Study of Ficerafusp Alfa in Combination With Nivolumab in Patients With Platinum-refractory Head and Neck Squamous Cell Carcinoma (N'FORCE)
Acronym N'FORCE
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Groupe Oncologie Radiotherapie Tete et Cou
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
Gustave Roussy RECRUITING Villejuif 94805 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field